AP187B
Goat Anti-Rabbit IgG Antibody, biotin-SP conjugate, Species Adsorbed
1.1 mg/mL, Chemicon®
Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych
About This Item
Kod UNSPSC:
12352203
eCl@ss:
32160702
NACRES:
NA.46
Polecane produkty
pochodzenie biologiczne
goat
Poziom jakości
białko sprzężone
biotin conjugate
forma przeciwciała
F(ab′)2 fragment of affinity isolated antibody
rodzaj przeciwciała
secondary antibodies
klon
polyclonal
reaktywność gatunkowa
rabbit
producent / nazwa handlowa
Chemicon®
stężenie
1.1 mg/mL
metody
ELISA: suitable
western blot: suitable
Warunki transportu
wet ice
docelowa modyfikacja potranslacyjna
unmodified
Specyficzność
Rabbit IgG (H+L) (absorbed for minimal cross-reactivity to Human, Mouse and Rat Serum Proteins)
Zastosowanie
Research Category
Secondary & Control Antibodies
Secondary & Control Antibodies
Research Sub Category
Secondary Antibodies Adsorbed for Dual Labeling
Secondary Antibodies Adsorbed for Dual Labeling
Suggested dilution for most applications:
1:50,000-1:1,000,000 for ELISA using enzyme-conjugated streptavidin
1:10,000-1:100,000 for western blotting with chemiluminescent substrates.
1:500-1:5,000 for enzyme immunoohistochemistry on tissue sections.
1:200-1:1,000 for flow cytometry and fluorescence immunohisto /cytochemistry
Optimal working dilutions must be determined by the end user.
1:50,000-1:1,000,000 for ELISA using enzyme-conjugated streptavidin
1:10,000-1:100,000 for western blotting with chemiluminescent substrates.
1:500-1:5,000 for enzyme immunoohistochemistry on tissue sections.
1:200-1:1,000 for flow cytometry and fluorescence immunohisto /cytochemistry
Optimal working dilutions must be determined by the end user.
This Goat anti-Rabbit IgG Antibody, biotin-SP conjugate, Species Adsorbed is validated for use in ELISA, WB for the detection of Rabbit IgG.
Postać fizyczna
Lyophilized. Buffer = 0.01 M Sodium Phosphate, 0.25 M NaCl, pH 7.6 with 15 mg/mL BSA, 0.01% Thimerosal and 0.05% Sodium Azide
RECONSTITUTION:
Reconstitute with 1.5 mL sterile distilled water.
RECONSTITUTION:
Reconstitute with 1.5 mL sterile distilled water.
Przechowywanie i stabilność
Maintain lyophilized product at 2-8°C for up to 12 months. After reconstitution the product is stable for several weeks at 2-8°C as an undiluted liquid. For extended storage after reconstitution, add an equal volume of glycerol to make a final concentration of 50% glycerol followed by storage at -20°C with or without aliquotting for up to 12 months. Please note the concentration of protein (and buffer salts) will decrease to one-half of the original after the addition of glycerol.
Informacje prawne
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Oświadczenie o zrzeczeniu się odpowiedzialności
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
This page may contain text that has been machine translated.
Nie możesz znaleźć właściwego produktu?
Wypróbuj nasz Narzędzie selektora produktów.
Zwroty wskazujące rodzaj zagrożenia
Zwroty wskazujące środki ostrożności
Klasyfikacja zagrożeń
Aquatic Chronic 3
Kod klasy składowania
11 - Combustible Solids
Klasa zagrożenia wodnego (WGK)
WGK 3
Certyfikaty analizy (CoA)
Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.
The presence of B-type natriuretic peptide in burns and the responsiveness of fibroblasts to BNP: proof of principle.
Adam J Singer,Vladimir Jurukovski,Marcia Simon,Jing Ying Ma,Andrew Protter et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine null
p38 MAPK inhibition reduces diabetes-induced impairment of wound healing.
Medicherla, S; Wadsworth, S; Cullen, B; Silcock, D; Ma, JY; Mangadu, R; Kerr et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy null
Jing Ying Ma et al.
Journal of asthma and allergy, 1, 31-44 (2008-01-01)
p38 Mitogen-activated protein kinase (MAPK) plays a critical role in the activation of inflammatory cells. We investigated the anti-inflammatory effects of a p38α-selective MAPK inhibitor (SD-282) in a mouse transgenic (CC10:IL-13) asthma model. The CC-10-driven over-expression of IL-13 in the
Expression of hepatocyte epidermal growth factor receptor, FAS and glypican 3 in EpCAM-positive regenerative clusters of hepatocytes, cholangiocytes, and progenitor cells in human liver failure.
Hattoum, A; Rubin, E; Orr, A; Michalopoulos, GK
Human Pathology null
Mitchell J Bartlett et al.
Experimental neurology, 333, 113413-113413 (2020-07-28)
Parkinson's disease (PD) is the second most common neurodegenerative disease. Pharmacotherapy with L-DOPA remains the gold-standard therapy for PD, but is often limited by the development of the common side effect of L-DOPA-induced dyskinesia (LID), which can become debilitating. The
Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.
Skontaktuj się z zespołem ds. pomocy technicznej